Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Biochem Biophys Res Commun ; 484(2): 385-389, 2017 03 04.
Artigo em Inglês | MEDLINE | ID: mdl-28130107

RESUMO

Synthesis of poly(ADP-ribose) (PAR) is catalyzed by PAR polymerase-1 (PARP-1) in neurons. PARP1 plays a role in various types of brain damage in neurodegenerative disorders. In neurons, overactivation of PARP-1 during oxidative stress induces robust PAR formation, which depletes nicotinamide adenine dinucleotide levels and leads to cell death. However, the role of the newly-formed PAR in neurodegenerative disorders remains elusive. We hypothesized that the effects of PAR could occur in the extracellular space after it is leaked from damaged neurons. Here we report that extracellular PAR (EC-PAR) functions as a neuroprotective molecule by inducing the synthesis of glial cell line-derived neurotrophic factor (GDNF) in astrocytes during neuronal cell death, both in vitro and in vivo. In primary rat astrocytes, exogenous treatment with EC-PAR produced GDNF but not other neurotrophic factors. The effect was concentration-dependent and did not affect cell viability in rat C6 astrocytoma cells. Topical injection of EC-PAR into rat striatum upregulated GDNF levels in activated astrocytes and improved pathogenic rotation behavior in a unilateral 6-hydroxydopamine model of Parkinson disease in rats. These findings indicate that EC-PAR acts as a neurotrophic enhancer by upregulating GDNF levels. This effect protects the remaining neurons following oxidative stress-induced brain damage, such as that seen with Parkinson disease.


Assuntos
Fator Neurotrófico Derivado de Linhagem de Célula Glial/metabolismo , Poli Adenosina Difosfato Ribose/metabolismo , Animais , Astrócitos/metabolismo , Linhagem Celular Tumoral , Células Cultivadas , Modelos Animais de Doenças , Espaço Extracelular/metabolismo , Técnicas In Vitro , Fatores de Crescimento Neural/metabolismo , Doença de Parkinson/terapia , Ratos , Ratos Wistar , Regulação para Cima
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA